Drawing for MAMMAL

USPTO serial 98317294

MAMMAL

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
LEIPZIG, MARC J
Law office
TMO LAW OFFICE 115

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with MAMMAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joanna Steblay

PO Box 23366Ventura, CA 93002United States

Goods and services

ClassDescriptionStatusFirst use
005Herbs for medicinal purposes; Medicinal herb extracts; Medicinal herbs in dried or preserved form; Herbal tea for medicinal purposes; Medicinal herbsACTIVE—
044Advisory services relating to health; Consulting services in the field of health; Health care services, namely, wellness programs; Health care services, namely, herbalism; Home health care services, namely, postpartum wellness; Lactation consulting services; Nutrition counseling; Wellness and health-related consulting services; Consulting in the field of health for women; Providing health information in the field of herbalism and women's healthACTIVE—
045Doula servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Aug 1, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 1, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 1, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 5, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Dec 4, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 3, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 31, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jan 31, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 21, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 21, 2024GNSLLETTER OF SUSPENSION E-MAILED—
Jul 21, 2024CNSLSUSPENSION LETTER WRITTEN—
Jul 16, 2024DOCKASSIGNED TO EXAMINER—
Mar 24, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 15, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance